News

Read our statement issued to the media about our #EpilepsyDay 2024 campaign!

In a welcome development for campaigners in the UK, a new report from the Patient Safety Commissioner has recommended that a redress scheme be set up quickly to help support families who have been impacted by Sodium Valproate.

Read more about our work with SUDEP Action as a result of the incredible Cycle for Shane.

An Epilepsy Ireland supported study is seeking feedback from women with epilepsy as they continue their important research.

EpiKNOW is currently investigating the health information and resource needs of women with epilepsy in Ireland, from preconception to postpartum.

Following an ongoing review of new data, the European Medicines agency’s Pharmacovigilance Risk Assessment Committee (PRAC) have announced new precautionary safety measures for the treatment of males with sodium valproate.

Our colleagues in Children's Health Ireland are currently conducting a research study in conjunction with Maynooth University which may be of interest to parents of children with epilepsy.

Our colleagues in the International Bureau for Epilepsy have launched another Virtual Art Exhibition for #EpilepsyDay 2024 - find out how to make a submission and showcase your creativity!

Epilepsy Ireland will officially close for the festive period on the 22^nd of December and will reopen on the 2^nd January.

Whether we can believe it or not, the final days of 2023 are fast approaching and as the year comes to an end, it allows us an opportunity to reflect on the successful year that was at Epilepsy Ireland.

If you are working in the DAA or know someone working in the DAA - we need YOUR help! Find out why.